SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
75.20
Ask:
78.80
Spread: 3.60 (4.787%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

Progressive Research Initiation Note Publication

11 Dec 2025 07:00

RNS Number : 0993L
Accsys Technologies PLC
11 December 2025
 

AIM: AXS

Euronext Amsterdam: AXS

 

11 December 2025

 

Accsys Technologies PLC

("Accsys", the "Group" or the "Company")

 

Progressive Research Initiation Note Publication

 

Accsys, the world's leading supplier of premium, high performance and sustainable wood building materials, has appointed Progressive Research to initiate coverage and provide ongoing equity research on the Group. An initiation research document by Alaistair Stewart was published on 9 December 2025 and is freely available to retail and institutional investors.

You can access the full note here.

Research note summary: Transformed product, transformative strategy

"Anglo-Dutch speciality timber products manufacturer Accsys Technologies stands to benefit from worldwide growth in demand for its technology to effectively transform softwood into hardwood. The six-year 'FOCUS' strategy, detailed by the new management team in January 2025, is already appearing transformative. We initiate coverage with an assumption that operational gearing and financial deleveraging will support a move to strong profitability by FY30E."

To be kept updated with future notes you can subscribe to Progressive's research.

 

Ends

Enquiries:

Accsys Investor Relations ir@accsysplc.com

 

Panmure Liberum (London) - Nomad and Broker

Nicholas How (NOMAD), Will King +44 (0) 20 3100 2000

 

ABN Amro (Amsterdam) - Broker

Richard van Etten, Dennis van Helmond +31 (0) 20 344 2000

 

Media: 

 

Camarco (UK) accsys@camarco.co.uk

Ginny Pulbrook, Tom Huddart, Tilly Butcher +44 (0)20 3757 4980

Huijskens Sassen Communications (NL)

Clemens Sassen, Tessa Nelissen +31 (0) 20 68 55 955

 

Notes to editors:

 

Accsys (Accsys Technologies PLC) is disrupting the building materials industry with its high-performance wood products and proprietary technology. Driven by its purpose of "changing wood to change the world", Accsys takes fast-growing, certified sustainable wood and turns it into long lasting, eco-friendly building materials - backed by warranties of up to 50 years. Operating in the rapidly growing global wood construction market, Accsys has an established manufacturing footprint in Europe and North America with active product distribution in more than 25 countries. Accsys is listed on the London Stock Exchange AIM market and on Euronext Amsterdam, under the symbols 'AXS'.

Accsys is a Participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business.

Visit www.accsysplc.com 

 

Accoya® is the global leader for high-performance wood. Created through a proprietary acetylation process developed by Accsys, Accoya delivers superior durability and stability, backed by an industry-leading warranty of up to 50 years. It holds Cradle to Cradle Certified® Gold (Full Scope - V3.1) status for its circular economy benefits. Combining the natural beauty of wood with exceptional performance, Accoya is the preferred choice for windows, doors, cladding, and decking - outperforming hardwoods and manmade materials in durability, stability, and sustainability.

Tricoya® acetylated wood chips redefine panel products, creating next-generation panels that thrive outdoors and in wet environments. Recognised as the biggest leap in wood composites in over 30 years, Tricoya panels combine the strength and versatility of traditional products with unmatched durability and eco-friendliness - backed by a warranty of up to 50 years - expanding design and construction possibilities like never before.

To find out more visit: www.accoya.com

Any references in this announcement to agreements with Accsys shall mean agreements with either Accsys or its subsidiary entities unless otherwise specified. 'Accsys' and 'Accsys Technologies' are trading names of Titan Wood Limited ("TWL"), a wholly-owned subsidiary of Accsys Technologies PLC. Accoya®, Tricoya® and the Trimarque Device are registered trademarks owned by TWL, and may not be used or reproduced without written permission from TWL, or in the case of the Tricoya® registered brand trademark, from Tricoya Technologies Limited, a subsidiary of TWL with exclusive rights to exploit the Tricoya® brand.

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAGPGBPPUPAPGU
Date   Source Headline
17th Aug 20124:27 pmRNSAccsys Employee Share Participation Plan
9th Aug 20127:01 amRNSInterim Management Statement
3rd Aug 20127:02 amRNSEmployee Share Participation Plan and Grant of Opt
27th Jul 20124:30 pmRNSTotal Voting Rights
24th Jul 20127:02 amRNSHeads of Terms with INEOS for joint venture
13th Jul 20129:18 amRNSDirector/PDMR Shareholding
11th Jul 20124:40 pmRNSSecond Price Monitoring Extn
11th Jul 20124:35 pmRNSPrice Monitoring Extension
10th Jul 20127:00 amRNSAnnual Results
5th Jul 20124:16 pmRNSDirectors' Interests
5th Jul 20129:02 amRNSAnnual results release date and webcast
2nd Jul 20127:02 amRNSAccoya® Licence Agreement with Solvay-Rhodia
30th Apr 20127:04 amRNSLicence Option Agreeement
29th Mar 20124:49 pmRNSNotifiable Interest
15th Mar 20125:24 pmRNSDirector/PDMR Shareholding
6th Mar 201210:21 amRNSBP Strategic Relationship
22nd Feb 20122:10 pmRNSTotal Voting Rights
21st Feb 20123:38 pmRNSNotifiable Interest
17th Feb 20127:01 amRNSInterim Management Statement
10th Feb 20124:35 pmRNSPrice Monitoring Extension
7th Feb 20124:52 pmRNSDirector Shareholding
7th Feb 201210:41 amRNSNotifiable Interest
27th Jan 20129:46 amRNSAnnual Information Update
24th Jan 201210:11 amRNSNotifiable Interest
18th Jan 20124:40 pmRNSSecond Price Monitoring Extn
18th Jan 20124:35 pmRNSPrice Monitoring Extension
16th Jan 20124:40 pmRNSSecond Price Monitoring Extn
16th Jan 20124:35 pmRNSPrice Monitoring Extension
3rd Jan 20122:08 pmRNSDirector/PDMR Shareholding
30th Dec 201112:40 pmRNSSecond Price Monitoring Extn
30th Dec 201112:35 pmRNSPrice Monitoring Extension
20th Dec 20114:40 pmRNSDirector/PDMR Shareholding
16th Dec 20113:34 pmRNSNotifiable Interest
9th Dec 20114:35 pmRNSPrice Monitoring Extension
6th Dec 20119:24 amRNSNotifiable Interest
30th Nov 20117:12 amRNSSeptember 2011 Interim Financial Statement
25th Nov 201112:22 pmRNSInterim results release date and webcast
2nd Nov 20114:40 pmRNSSecond Price Monitoring Extn
2nd Nov 20114:35 pmRNSPrice Monitoring Extension
21st Oct 20118:28 amRNSAppointment of Nominated Advisor and broker
8th Sep 20113:25 pmRNSResult of AGM
31st Aug 20119:05 amRNSTotal Voting Rights
10th Aug 20117:01 amRNSInterim Management Statement
4th Aug 20114:40 pmRNSSecond Price Monitoring Extn
4th Aug 20114:35 pmRNSPrice Monitoring Extension
1st Aug 201111:42 amRNSEmployee Share Plan and Grant of Options
20th Jul 20112:02 pmRNSNotice of Annual General Meeting
5th Jul 201111:52 amRNSChange of Registered Office
30th Jun 20117:00 amRNSAnnual Financial Report
28th Jun 20117:01 amRNSAnnual results release date and webcast

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.